TickerFactsScreenerDevelopers

Evofem Biosciences, Inc. (EVFM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$41.76M2013: -$56.69M2014: $65.25M2015: $23.81M2016: -$181.09M2017: -$289.55M2018: -$23.36M2019: $15.64M2020: $1.35M2021: -$104.31M2022: -$71.80M2023: -$66.51M2024: -$71.26M2025: -$74.34M-$74.34M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$74.34M-4.3%
2024-$71.26M-7.1%
2023-$66.51M+7.4%
2022-$71.80M+31.2%
2021-$104.31M-7844.2%
2020$1.35M-91.4%
2019$15.64M+166.9%
2018-$23.36M+91.9%
2017-$289.55M-59.9%
2016-$181.09M-860.6%
2015$23.81M-63.5%
2014$65.25M+215.1%
2013-$56.69M-35.8%
2012-$41.76M—